Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|March 13, 2024
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanomaXiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 20, 2024
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective StudyLongbin Xiong, Xingli Shan, Huali Ma, et al.Journal of Multidisciplinary Healthcare|March 3, 2023
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma PatientsYuhao Zeng, Sha Zhu, Zilin Wang, et al.Genome Medicine|May 2, 2023
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinomaJiayu Liang, Guangxi Sun, Xiuyi Pan, et al.JAMA Network Open|June 15, 2026
Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical TrialXin Wang, Ouying Yan, Jitao Zhou, et al.European Urology Oncology|November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial CancerOmar Alhalabi, Yueting Zhu, Ameer Hamza, et al.Cancer Research|October 17, 2023
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the ProstateJinge Zhao, Nanwei Xu, Sha Zhu, et al.Nature Communications|September 7, 2021
Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinomaGuangxi Sun, Junru Chen, Jiayu Liang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell CarcinomaGuangxi Sun, Xingming Zhang, Jiayu Liang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2024
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell CarcinomaJunru Chen, Xu Hu, Junjie Zhao, et al.Pageof 21